Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation.
van Kuilenburg ABP, Hollak CEM, Travella A, Jacobs M, Gentilini LD, Leen R, der Vlugt KMMG, Stet FSB, Goorden SMI, van der Veen S, Criscuolo M, Papouchado M.
van Kuilenburg ABP, et al. Among authors: gentilini ld.
Drugs R D. 2023 Jun;23(2):141-153. doi: 10.1007/s40268-023-00421-x. Epub 2023 Apr 21.
Drugs R D. 2023.
PMID: 37083901
Free PMC article.